Bromocriptine has little direct effect on murine lymphocytes, the immunomodulatory effect being mediated by the suppression of prolactin secretion

Biomedicine and Pharmacotherapy

Volumn 51, Issue 3, 1997, Pages 118-125

  Neidhart, M ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

bromocriptine; interleukin 2; lymphocytes; murine lupus

Indexed keywords

BROMOCRIPTINE; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL PROLIFERATION; CYTOTOXICITY; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROLACTIN RELEASE; SPLEEN CELL; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0030964485     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0753-3322(97)86909-0     Document Type: Article

References (30)

1. 1 Neidhart M. Bromocriptine microcapsules inhibit ornithine decarboxylase activity induced by Freund's complete adjuvant in lymphoid tissues of male rats. Endocrinology 1989;125:2846-52
2. 2 McMurray R, Keisler D, Kanuckei K, Izui S, Walker SE. Prolactin influences autoimmune disease activity in the female B/W mouse. J Immunol 1991;3780-87
3. 3 Jara LJ, Gomez-Sanchez C, Silveira LH, Martinez-Osuna P, Vasey FB, Espinoza LR. Hyperprolactinemia in systemic lupus erythematosus : association with disease activity. Am J Med Sci 1992;303:222-6
4. 4 McMurray RW, Allen SH, Braun AL, Rodriguez F, Walker SE. Long-standing hyperprolactinemia associated with systemic lupus erythematosus : possible hormonal stimulation of an autoimmune disease. J Rheumatol 1994, 21:843-50
5. 5 Neidhart M. Elevated serum prolactin or elevated prolactin/cortisol ratio are associated with autoimmune processes in systemic lupus erythematosus and other connective tissue diseases. J Rheumatol 1996;23:476-81
6. 6 McMurray RW, Weidensaul D, Allen SH, Walker SE. Efficacy of bromocriptine in an open label therapeutic trial for systemic lupus erythematosus. J Rheumatol 1995;22:2084-91
7. 7 Alvarez-Nemegyei J, Covarrubias-Cobos A, Escalante-Triay F, Sosa-Muñoz J, Jara LJ. Bromocriptine in systemic lupus erythematosus : a double-blind, randomized, placebo-controlled study. Arthritis Rheum 1996;39 (suppl):S253 (abstract)
8. 8 McMurray RW, Weidensaul D, Nelson W, Smarr K, Parker J, Walker SE. Relationship of psychological state, disease activity, and prolactin in systemic lupus erythematosus. Arthritis Rheum 1996;39 (suppl):S295 (abstract)
9. 9 Morikawa K, Oseko F, Morikawa S. Immunosuppressive property of bromocriptine on human B lymphocyte function in vitro. Clin Exp Immunol 1993;93:200-5
10. 10 Morikawa K, Oseko F, Morikawa S. Immunosuppressive activity of bromocriptine on human T lymphocyte function in vitro. Clin Exp Immunol 1994;95:514-518
11. 11 Hawkins TA, Gala RR, Dunbar JC. Prolactin modulates the incidence of diabetes in male and female NOD mice. Autoimmunity 1994;18:155-62
12. 12 Segre M, Segre D. Behavior of the idiotypic network in conventional immune responses. III. Detection and enumeration of cells producing idiotypic and anti-idiotypic antibodies by a spot ELISA technique. Cell Immunol 1994;159:40-8
13. 13 Wilson GL, Bellomo SC, Craighead JE. Effect of interferon on encephalomyocarditis virus infection of cultured mouse pancreatic B cells. Diabetologia 1983:24:38-41
14. 14 Kupper TS, Coleman DL, McGuire J, Goldminz D, Horowitz MC. Keratinocyte-derived T-cell growth factor functionally distinct from interleukin-2. Proc Natl Acad Sci USA 1986;83:4451-4455
15. 15 Yamashita, T, Boros DL. Changing patterns of lymphocyte proliferation, IL-2 production and utilization, and IL-2 receptor expression in mice infected with Schistosoma mansoni. J Immunol 1990:145:724-31
16. 16 Ichikawa A, Takagi M, Tomita K. Effect of D-glucosamine on growth and several functions of cultured mastocytoma P-815 cells. J Pharmacobiodyn 1980:3:577-88
17. 17 Roth J, Brown D, Norman AW, Orci L. Localization of the vitamin D-dependent calcium binding protein in mammalian kidney. Am J Physiol 1982; 243:F243-52
18. 18 Kouassi E, Boukhris W, Descotes J, Zukervar P, Li YS, Revillard JP. Selective T cell defects induced by dopamine administration in mice. Immunopharmacol Immunotoxicol 1987;9:477-88
19. 19 Koff WC, Dunegan MA. Neuroendocrine hormones suppress macrophage-mediated lysis of herpes simplex virus-infected cells. J Immunol 1986; 136:705-9
20. 20 Dijkmans BA, de Vries E, de Vreede TM, Cats A. Effects of anti-rheumatic drugs on in vitro mitogenic stimulation of peripheral blood mononuclear cells. Transplant Proc 1988;20 (suppl 2):253-8
21. 21 Bernton EW, Meltzer MS, Holaday JW. Suppression of macrophage activation and T-lymphocyte function in hypoprolactinemic mice. Science 1988;239:401-4
22. 22 Issell BF, Tihon C, Curry ME. Etoposide (VP16-213) and teniposide (VM26) comparative in vitro activities in human tumors. Cancer Chemother Pharmacol 1982;7:113-5
23. 23 McMurray R, Keisler D, Izui S, Walker SE. Hyperprolactinemia in male NZB/NZW (B/W) F1 mice: accelerated autoimmune disease with normal circulating testosterone. Clin Immunol Immunopathol 1994;71:338-43
24. 24 Walker SE, McMurray RW, Besch-Williford CL, Keisler DH. Premature death with bladder outlet obstruction and hyperprolactinemia in New Zealand black x New Zealand white mice treated with ethinyl estradiol and 17 beta-estradiol. Arthritis Rheum 1992;35:1387-92
25. 25 Viselli SM, Stanek EM, Mukherjee P, Hymer WC, Mastro AM. Prolactin-induced mitogenesis of lymphocytes from ovariectomized rats. Endocrinology 1991; 129:983-90
26. 26 Gaufo GO, Diamond, MC. Prolactin increases CD4/CD8 cell ratio in thymus-grafted congenitally athymic nude mice. Proc Natl Acad Sci USA 1996; 93:4165-9
27. 27 Blank M, Krause I, Buskila D et al. Bromocriptine immunomodulation of experimental SLE and primary antiphospholipid syndrome via induction of nonspecific T suppressor cells. Cell Immunol 1995;162:114-22
28. 28 Jara LJ, Lavalle C, Fraga A et al. Prolactin, immunoregulation, and autoimmune diseases. Semin Arthritis Rheum 1991;20:273-84
29. 29 Gala RR, Shevach EM. Influence of bromocriptine administration to mothers on the development of pup thymocyte and splenocyte subsets and on mitogen-induced proliferation in the mouse. Life Sci 1993;53:1981-94
30. 30 Neidhart M. Synergism between long-acting bromocriptine microcapsules and cyclosporin A in the prevention of various autoimmune diseases in rats. Experientia 1996;52:892-9